Alex Sapir
CIK: 0001709415
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
FULC
Fulcrum Therapeutics, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
About Sapir Alex
Sapir Alex (SEC CIK 0001709415) files insider reports with the SEC as Director of Fulcrum Therapeutics, Inc. (FULC).
Signal8 holds 2 ownership filings by Sapir Alex, all Form 4s, filed between Jan 28, 2025 and Feb 4, 2026. Those filings report 2 transactions, from Jan 24, 2025 to Feb 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Sapir Alex's filings is in CAMBRIDGE, MA.
Recent filings by Sapir Alex
Other insiders filing for Fulcrum Therapeutics, Inc. (FULC)
- TANG KEVIN, 10% Owner
- Banks Sonja, Director
- Dorton Katina, Director
- Gould Robert J, Director
- Haviland Kate, Director
- King Rachel K., Director